Accenture announced it is accepting applications for the third annual Accenture HealthTech Innovation Challenge (#HealthTechChallenge on twitter), which aims to improve the way people access and manage healthcare. It brings together startups with health and life sciences companies to tackle some of the world’s greatest health challenges, including access, quality, and affordability-of-care options.
The three categories for the third annual Accenture HealthTech Innovation Challenge are:
Key criteria that applications should address include solution innovation, solution design quality, disruptive business model, potential impact on patient outcomes, and solution scalability.
Emerging healthcare technology innovators and disruptors are encouraged to apply for the program by clicking here now through Sept. 1.
What Every Pharma CEO Should Know About Unlocking the Potential of Scientific Data
December 11th 2024When integrated into pharmaceutical enterprises, scientific data has the potential to drive organizational growth and innovation. Mikael Hagstroem, CEO at leading laboratory informatics provider LabVantage Solutions, discusses how technology partners add significant value to pharmaceutical R&D, in addition to manufacturing quality.
Key Findings of the NIAGARA and HIMALAYA Trials
November 8th 2024In this episode of the Pharmaceutical Executive podcast, Shubh Goel, head of immuno-oncology, gastrointestinal tumors, US oncology business unit, AstraZeneca, discusses the findings of the NIAGARA trial in bladder cancer and the significance of the five-year overall survival data from the HIMALAYA trial, particularly the long-term efficacy of the STRIDE regimen for unresectable liver cancer.